Literature DB >> 22529712

Laboratory confirmation of Lyme disease.

T G Schwan1, W J Simpson, P A Rosa.   

Abstract

Lyme disease can be confirmed in the laboratory by isolation or detection of its causative agent, a tick-borne spirochete Borrelia burgdorferi, or by a diagnostic change in the titre of antibodies specific to the agent. B burgdorferi can be isolated and cultivated in Barbour-Stoenner-Kelly II medium. It can be detected by light microscopy in tissue sections or, rarely, in blood smears using various staining methods. There is interest in the development of alternative detection methods, including identification of specific antigens of B burgdorferi in the urine of suspected cases and demonstration of the presence of species-specific DNA using polymerase chain reaction assays. Currently, serological tests (indirect immunofluorescence assay, enzyme-linked immunosorbent assay and Western immunoblot) are the most practical and available methods for confirming Lyme disease. The quest to improve the specificity and sensitivity of serological tests - for example, through the use of specific recombinant antigens - continues.

Entities:  

Keywords:  Borrelia burgdorferi; Enzyme-linked immunosorbent assay; Indirect immunofluorescence assay; Laboratory confirmation; Western immunoblot

Year:  1991        PMID: 22529712      PMCID: PMC3327992          DOI: 10.1155/1991/637201

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  53 in total

1.  Quality of Lyme disease tests.

Authors:  L A Magnarelli
Journal:  JAMA       Date:  1989 Dec 22-29       Impact factor: 56.272

Review 2.  Lyme disease: of ticks and titers.

Authors:  A H Eichenfield; B H Athreya
Journal:  J Pediatr       Date:  1989-02       Impact factor: 4.406

Review 3.  The diagnosis of Lyme disease: rewards and perils.

Authors:  A G Barbour
Journal:  Ann Intern Med       Date:  1989-04-01       Impact factor: 25.391

4.  Serodiagnosis of early Lyme disease: analysis of IgM and IgG antibody responses by using an antibody-capture enzyme immunoassay.

Authors:  V P Berardi; K E Weeks; A C Steere
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

5.  Erythema chronicum migrans of Lyme disease: diagnosis by monoclonal antibodies.

Authors:  H K Park; B E Jones; A G Barbour
Journal:  J Am Acad Dermatol       Date:  1986-08       Impact factor: 11.527

6.  Identification and characterization of an endoflagellar antigen of Borrelia burgdorferi.

Authors:  J L Coleman; J L Benach
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

7.  Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi.

Authors:  R J Dattwyler; D J Volkman; B J Luft; J J Halperin; J Thomas; M G Golightly
Journal:  N Engl J Med       Date:  1988-12-01       Impact factor: 91.245

8.  Antibody response in white-footed mice (Peromyscus leucopus) experimentally infected with the Lyme disease spirochete (Borrelia burgdorferi).

Authors:  T G Schwan; K K Kime; M E Schrumpf; J E Coe; W J Simpson
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

Review 9.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  1989-08-31       Impact factor: 91.245

10.  Efficacy of the urinary bladder for isolation of Borrelia burgdorferi from naturally infected, wild Peromyscus leucopus.

Authors:  S M Callister; W A Agger; R F Schell; K M Brand
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

View more
  1 in total

1.  Serodiagnosis of Louse-Borne relapsing fever with glycerophosphodiester phosphodiesterase (GlpQ) from Borrelia recurrentis.

Authors:  S F Porcella; S J Raffel; M E Schrumpf; M E Schriefer; D T Dennis; T G Schwan
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.